These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 14508064

  • 1. Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling.
    Sung YK, Hwang SY, Farooq M, Kim JC, Kim MK.
    Exp Mol Med; 2003 Aug 31; 35(4):257-62. PubMed ID: 14508064
    [Abstract] [Full Text] [Related]

  • 2. Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells.
    Sakurai M, Shibata K, Umezu T, Kajiyama H, Yamamoto E, Ino K, Nawa A, Kikkawa F.
    Gynecol Oncol; 2010 Nov 31; 119(2):332-6. PubMed ID: 20701957
    [Abstract] [Full Text] [Related]

  • 3. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
    Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A.
    Dev Biol; 2002 Mar 01; 243(1):185-206. PubMed ID: 11846487
    [Abstract] [Full Text] [Related]

  • 4. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H.
    Int J Cancer; 2003 Feb 10; 103(4):455-65. PubMed ID: 12478660
    [Abstract] [Full Text] [Related]

  • 5. Glypican-3 expression is silenced in human breast cancer.
    Xiang YY, Ladeda V, Filmus J.
    Oncogene; 2001 Nov 01; 20(50):7408-12. PubMed ID: 11704870
    [Abstract] [Full Text] [Related]

  • 6. Expression of glypican 3 (GPC3) in embryonal tumors.
    Saikali Z, Sinnett D.
    Int J Cancer; 2000 Sep 20; 89(5):418-22. PubMed ID: 11008203
    [Abstract] [Full Text] [Related]

  • 7. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
    Lin H, Huber R, Schlessinger D, Morin PJ.
    Cancer Res; 1999 Feb 15; 59(4):807-10. PubMed ID: 10029067
    [Abstract] [Full Text] [Related]

  • 8. Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest.
    Farooq M, Hwang SY, Park MK, Kim JC, Kim MK, Sung YK.
    Mol Cells; 2003 Jun 30; 15(3):356-60. PubMed ID: 12872992
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.
    Peters MG, Farías E, Colombo L, Filmus J, Puricelli L, Bal de Kier Joffé E.
    Breast Cancer Res Treat; 2003 Jul 30; 80(2):221-32. PubMed ID: 12908826
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis.
    Pan Z, Chen C, Long H, Lei C, Tang G, Li L, Feng J, Chen F.
    Mol Med Rep; 2013 Mar 30; 7(3):969-74. PubMed ID: 23338845
    [Abstract] [Full Text] [Related]

  • 11. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
    Hartwig S, Hu MC, Cella C, Piscione T, Filmus J, Rosenblum ND.
    Mech Dev; 2005 Jul 30; 122(7-8):928-38. PubMed ID: 15925496
    [Abstract] [Full Text] [Related]

  • 12. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH, Cooper K.
    Adv Anat Pathol; 2009 Mar 30; 16(2):125-9. PubMed ID: 19550373
    [Abstract] [Full Text] [Related]

  • 13. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.
    Capurro MI, Xiang YY, Lobe C, Filmus J.
    Cancer Res; 2005 Jul 15; 65(14):6245-54. PubMed ID: 16024626
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
    Ruan J, Liu F, Chen X, Zhao P, Su N, Xie G, Chen J, Zheng D, Luo R.
    Int J Mol Med; 2011 Oct 15; 28(4):497-503. PubMed ID: 21617840
    [Abstract] [Full Text] [Related]

  • 15. Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells.
    Kwack MH, Choi BY, Sung YK.
    Mol Cells; 2006 Apr 30; 21(2):224-8. PubMed ID: 16682817
    [Abstract] [Full Text] [Related]

  • 16. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
    Veugelers M, Vermeesch J, Watanabe K, Yamaguchi Y, Marynen P, David G.
    Genomics; 1998 Oct 01; 53(1):1-11. PubMed ID: 9787072
    [Abstract] [Full Text] [Related]

  • 17. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
    Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D.
    Nat Genet; 1996 Mar 01; 12(3):241-7. PubMed ID: 8589713
    [Abstract] [Full Text] [Related]

  • 18. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
    Filmus J, Capurro M.
    FEBS J; 2013 May 01; 280(10):2471-6. PubMed ID: 23305321
    [Abstract] [Full Text] [Related]

  • 19. Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling.
    Capurro M, Martin T, Shi W, Filmus J.
    J Cell Sci; 2014 Apr 01; 127(Pt 7):1565-75. PubMed ID: 24496449
    [Abstract] [Full Text] [Related]

  • 20. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
    Murthy SS, Shen T, De Rienzo A, Lee WC, Ferriola PC, Jhanwar SC, Mossman BT, Filmus J, Testa JR.
    Oncogene; 2000 Jan 20; 19(3):410-6. PubMed ID: 10656689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.